Acquired high-titer factor VIII inhibitor:: fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmaphereses

被引：33

作者：

Fischer, KG ^{[1
]}

Deschler, B ^{[1
]}

Lübbert, M ^{[1
]}

机构：

[1] Univ Hosp Freiburg, Dept Med, Div Nephrol & Gen Med, D-79106 Freiburg, Germany

来源：

BLOOD | 2003年 / 101卷 / 09期

关键词：

D O I：

10.1182/blood-2002-12-3920

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3753 / 3754

页数：2

共 10 条

[1] PORCINE FACTOR-VIII AND PLASMAPHERESIS IN THE MANAGEMENT OF HEMOPHILIAC PATIENTS WITH INHIBITORS [J].

BONA, RD ;

PASQUALE, DN ;

KALISH, RI ;

WITTER, BA .

AMERICAN JOURNAL OF HEMATOLOGY, 1986, 21 (02) :201-207

[2] Severe cold hemagglutinin disease (CHD) successfully treated with rituximab [J].

Engelhardt, M ;

Jakob, A ;

Rüter, B ;

Trepel, M ;

Hirsch, F ;

Lübbert, M .

BLOOD, 2002, 100 (05) :1922-1923

[3]

Golay J, 2000, BLOOD, V95, P3900

[4]

GREEN D, 1993, THROMB HAEMOSTASIS, V70, P753

[5] Treating human autoimmune disease by depleting B cells [J].

Looney, RJ .

ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :863-866

[6] ACQUIRED HEMOPHILIA - A NATURAL-HISTORY STUDY OF 16 PATIENTS WITH FACTOR-VIII INHIBITORS RECEIVING LITTLE OR NO THERAPY [J].

LOTTENBERG, R ;

KENTRO, TB ;

KITCHENS, CS .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (06) :1077-1081

[7] RECOMBINANT FACTOR-VIII FOR THE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - SAFETY, EFFICACY, AND DEVELOPMENT OF INHIBITORS [J].

LUSHER, JM ;

ARKIN, S ;

ABILDGAARD, CF ;

SCHWARTZ, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (07) :453-459

[8] USE OF RECOMBINANT ACTIVATED FACTOR-VII FOR TREATMENT OF A RETROPHARYNGEAL HEMORRHAGE IN A HEMOPHILIC PATIENT WITH A HIGH TITER INHIBITOR [J].

MACIK, BG ;

HOHNEKER, J ;

ROBERTS, HR ;

GRIFFIN, AM .

AMERICAN JOURNAL OF HEMATOLOGY, 1989, 32 (03) :232-234

[9] Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia [J].

Sallah, S ;

Wan, JY .

BLOOD, 2003, 101 (03) :943-945

[10] Rituximab in the treatment of acquired factor VIII inhibitors [J].

Wiestner, A ;

Cho, HJ ;

Asch, AS ;

Michelis, MA ;

Zeller, JA ;

Peerschke, EIB ;

Weksler, BB ;

Schechter, GP .

BLOOD, 2002, 100 (09) :3426-3428

← 1 →